Novan Reports Full Year 2022 Financial Results and Provides Corporate Update

– Berdazimer gel, 10.3% (SB206) assigned PDUFA goal date of January 5, 2024 –

– Strong year-over-year prescription growth across three promoted products, RHOFADE, WYNZORA and MINOLIRA –